We are live on ! Find out more
WST icon

West Pharmaceutical
WST

205 hedge funds and large institutions have $2.55B invested in West Pharmaceutical in 2013 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 75 increasing their positions, 84 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 13

17% more capital invested

Capital invested by funds: $2.19B → $2.55B (+$364M)

4% more funds holding

Funds holding: 197 → 205 (+8)

2.43% less ownership

Funds ownership: 180.46% → 178.02% (-2.4%)

11% less repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 84

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

Holders
205
Holders Change
+8
Holders Change %
+4.06%
% of All Funds
6.65%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.19%
New
23
Increased
75
Reduced
84
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BAMCO Inc
BAMCO Inc
New York
+$32.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$29.7M
3
RIM
RS Investment Management
California
+$23.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$16.2M
5
BFA
BlackRock Fund Advisors
California
+$16M

Top Sellers

Rank Fund Capital Flow
1
HIM
Hermes Investment Management
United Kingdom
-$28.5M
2
CIP
Champlain Investment Partners
Vermont
-$27.8M
3
Northern Trust
Northern Trust
Illinois
-$17.5M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$16.9M
5
DIA
Denver Investment Advisors
Colorado
-$15.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
ProShare Advisors
101
ProShare Advisors
Maryland
$1.94M -$49.4K -1,294 -3%
Allianz Asset Management
102
Allianz Asset Management
Germany
$1.89M +$6.1K +160 +0.3%
CAM
103
ClariVest Asset Management
California
$1.84M -$1.19M -31,224 -41%
Citadel Advisors
104
Citadel Advisors
Florida
$1.74M -$3.93M -103,007 -71%
AAM
105
Advisors Asset Management
Colorado
$1.72M +$371K +9,713 +30%
BA
106
BlackRock Advisors
Delaware
$1.7M +$20.4K +536 +1%
OSAM
107
O'Shaughnessy Asset Management
Connecticut
$1.64M -$1.75M -45,750 -53%
Jacobs Levy Equity Management
108
Jacobs Levy Equity Management
New Jersey
$1.6M – – –
CAM
109
Capstone Asset Management
Texas
$1.53M +$54.2K +1,420 +4%
CIM
110
Confluence Investment Management
Missouri
$1.44M -$166K -4,362 -11%
FMT
111
First Mercantile Trust
Tennessee
$1.41M -$172K -4,500 -12%
SIM
112
Spark Investment Management
New York
$1.37M +$481K +12,600 +61%
D.E. Shaw & Co
113
D.E. Shaw & Co
New York
$1.26M -$3.91M -102,370 -77%
GC
114
Globeflex Capital
California
$1.25M – – –
ZIM
115
Zacks Investment Management
Illinois
$1.25M -$112K -2,942 -9%
MAM
116
Martingale Asset Management
Massachusetts
$1.24M -$450K -11,800 -28%
NSEDCP
117
NJ State Employees Deferred Compensation Plan
New Jersey
$1.24M – – –
OC
118
Oppenheimer & Co
New York
$1.24M – – –
TRSOTSOK
119
Teachers Retirement System of the State of Kentucky
Kentucky
$1.18M -$214K -5,600 -16%
PA
120
Profund Advisors
Maryland
$1.18M +$446K +11,692 +69%
VRS
121
Virginia Retirement Systems
Virginia
$1.17M – – –
GIA
122
GHP Investment Advisors
Colorado
$1.14M +$18.8K +492 +2%
CCG
123
Chatham Capital Group
Georgia
$1.05M – – –
Thrivent Financial for Lutherans
124
Thrivent Financial for Lutherans
Minnesota
$1.04M – – –
Federated Hermes
125
Federated Hermes
Pennsylvania
$1.01M -$1.56M -40,875 -63%
3 4
5
6 7

WST Hedge Fund Activity: Q3 2013 in Review

205 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2013, worth a combined $2.55B — up 17% from $2.19B a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new WST positions and 13 closed out — a net gain of 10 holders — while 75 added to existing stakes and 84 trimmed.

The largest buyer was BAMCO Inc, adding an estimated $32.7M. The largest seller was Hermes Investment Management, cutting an estimated $28.5M.

  • 205 institutional investors held West Pharmaceutical (WST) as of Q3 2013, up from 197 in Q2 2013.
  • Funds reported $2.55B of West Pharmaceutical stock for Q3 2013, up 17% quarter-over-quarter.
  • 23 funds opened new West Pharmaceutical positions in Q3 2013 and 13 closed out, a net change of +10 holders.
  • The largest West Pharmaceutical buyer in Q3 2013 was BAMCO Inc, an estimated $32.7M added.
  • The largest West Pharmaceutical seller in Q3 2013 was Hermes Investment Management, an estimated $28.5M sold.

Based on aggregated 13F filings for Q3 2013.